foscarnet has been researched along with Chicken Pox in 10 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " These questions concern appropriate routes of administration for antiviral compounds, optimal dosage regimens, risks of long-term prophylaxis, and the emergence of resistant organisms." | 2.66 | Antiviral chemotherapy and chemoprophylaxis. ( Dolin, R, 1985) |
| "There are no published data on varicella in HIV-infected adults, however, probably because most adults have already experienced varicella prior to HIV infection." | 2.41 | Prevention and treatment of VZV infections in patients with HIV. ( Gershon, AA, 2001) |
| "The alphaherpesvirus varicella-zoster virus (VZV) causes chickenpox and shingles." | 1.40 | β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism. ( Arnold, RD; Chavre, S; Chu, CK; De, C; Hagen, FK; Liu, D; Moffat, JF; Singh, US; White, C; Zheng, B, 2014) |
| "Among the atypical forms of chronic varicella, this eruption appears to be unique." | 1.29 | Chronic varicella presenting as disseminated pinpoint-sized papules in a man infected with the human immunodeficiency virus. ( Castanet, J; Durant, J; Lacour, JP; Ortonne, JP; Perrin, C; Rodot, S; Van Elslande, L, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De, C | 1 |
| Liu, D | 1 |
| Zheng, B | 1 |
| Singh, US | 1 |
| Chavre, S | 1 |
| White, C | 1 |
| Arnold, RD | 1 |
| Hagen, FK | 1 |
| Chu, CK | 1 |
| Moffat, JF | 1 |
| Brown, TJ | 1 |
| McCrary, M | 1 |
| Tyring, SK | 1 |
| Hatchette, T | 1 |
| Tipples, GA | 1 |
| Peters, G | 1 |
| Alsuwaidi, A | 1 |
| Zhou, J | 1 |
| Mailman, TL | 1 |
| Sanz Moreno, J | 1 |
| López-Rubio, M | 1 |
| Calero-García, MA | 1 |
| Ratia-Jiménez, T | 1 |
| Arranz-Caso, A | 1 |
| Martínez-Martínez, J | 1 |
| Castanet, J | 1 |
| Rodot, S | 1 |
| Lacour, JP | 1 |
| Van Elslande, L | 1 |
| Perrin, C | 1 |
| Durant, J | 1 |
| Ortonne, JP | 1 |
| Smith, NA | 1 |
| Wood, C | 1 |
| Asboe, D | 1 |
| Bingham, JS | 1 |
| Visse, B | 1 |
| Huraux, JM | 1 |
| Fillet, AM | 1 |
| Crassard, N | 1 |
| Souillet, AL | 1 |
| Morfin, F | 1 |
| Thouvenot, D | 1 |
| Claudy, A | 1 |
| Bertrand, Y | 1 |
| Gershon, AA | 1 |
| Dolin, R | 1 |
3 reviews available for foscarnet and Chicken Pox
| Article | Year |
|---|---|
Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Chickenpox; Cytomegalovirus Infections; Famciclovir; Fos | 2002 |
Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature.
Topics: Acyclovir; Chickenpox; Child; Drug Resistance, Viral; Female; Foscarnet; Herpesvirus 3, Human; Human | 2008 |
Prevention and treatment of VZV infections in patients with HIV.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Chickenpox; Chickenpox Va | 2001 |
1 trial available for foscarnet and Chicken Pox
| Article | Year |
|---|---|
Antiviral chemotherapy and chemoprophylaxis.
Topics: Acyclovir; Adult; Aged; Amantadine; Antiviral Agents; Chickenpox; Clinical Trials as Topic; Cytomega | 1985 |
6 other studies available for foscarnet and Chicken Pox
| Article | Year |
|---|---|
β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.
Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Chickenpox; Dioxolanes; Drug The | 2014 |
Acute abdomen and intestinal necrosis produced by varicella-zoster virus in an immunocompromised host.
Topics: Abdomen, Acute; Aged; Antiviral Agents; Chickenpox; Fatal Outcome; Female; Foscarnet; Herpesvirus 3, | 1996 |
Chronic varicella presenting as disseminated pinpoint-sized papules in a man infected with the human immunodeficiency virus.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Chickenpox; Chronic Disea | 1996 |
Topical foscarnet for aciclovir-resistant mucocutaneous herpes infections in AIDS.
Topics: Acyclovir; Administration, Topical; Antiviral Agents; Chickenpox; Drug Resistance, Microbial; Foscar | 1997 |
Point mutations in the varicella-zoster virus DNA polymerase gene confers resistance to foscarnet and slow growth phenotype.
Topics: Amino Acid Sequence; Antiviral Agents; Chickenpox; Child; DNA-Directed DNA Polymerase; DNA, Viral; D | 1999 |
Acyclovir-resistant varicella infection with atypical lesions in a non-HIV leukemic infant.
Topics: Acyclovir; Antiviral Agents; Chickenpox; Drug Resistance; Foscarnet; Herpesvirus 3, Human; HIV Seron | 2000 |